Carrie Liu of the World Economic Forum, Dr Chang Liu, founder and CEO of ASK Health Asia, and Associate Professor Jonas Karlstrom, Innovation Core Lead at SingHealth Duke-NUS Global Health Institute moderated the event. In the opening remarks, the hosts shared how this year’s summit marked the establishment of the APAC Health and Life Science Partnership Platform, a collaborative initiative uniting public and private stakeholders to drive transformative solutions and foster equitable access to high-quality care across the Asia and Pacific region. The Singapore Economic Development Board (EDB) highlighted the importance of innovation in healthcare and life sciences for Asia’s rapidly evolving landscape and reaffirmed Singapore’s strategic role in facilitating collaboration and creating value across the region.

Partnering and Innovating for Equity and Access Across APAC

The first morning of the summit focused on two key topics, “The APAC Growth Story” and “The APAC Life Science Innovation Landscape,” offering valuable insights into the region’s dynamic development and innovation potential.

A Country Highlights session featured insights from Australia, India and China. Dr Paul Huleatt, Counsellor (Health) at the Australian High Commission, Singapore, and Regional Advisor for the Indo-Pacific Regulatory Strengthening Program, underscored that strengthening regulatory frameworks in the Asia Pacific region depends on collaborative partnerships, evidence-based decision making and the continuous improvement of regulatory practices. Siddhartha Bhattacharya, Secretary General of NATHEALTH, highlighted key opportunities in India’s healthcare, focusing on innovation, digital health, infrastructure and global integration through public-private partnerships. ? Lin Shi, Policy Director of PhRMA China Office, stated, “China’s biopharmaceutical R&D pipeline has grown by 784% over the past decade, becoming the second largest globally after the United States. This growth was driven by supportive policies such as regulatory reforms. An innovative biopharmaceutical ecosystem is key to continue to enhance innovation and improve patient access.”

Dr Snehal Patel, Co-founder of aEQ and Managing Director of Saena Partners, and Carrie Liu, Lead for Health and Healthcare at the World Economic Forum, moderated panels that explored cross-regional health innovation and the development of a supportive ecosystem for life sciences in APAC. Speakers from the Health and Global Policy Institute (HGPI) Japan, Australian High Commission Singapore, ProtectHealth Corporation and Ministry of Health Malaysia, the American Chamber of Commerce in Singapore, Bristol Myers Squibb, Eli Lilly and Apollo Hospitals shared their perspectives on cross-regional cooperation to advance health equity and access. The panel underscored the importance of innovation and regulatory harmonization in addressing challenges and improving health outcomes for all. They discussed specific models of stakeholder collaboration that have had measurable impact on access and how to take those lessons and apply them to other areas of need.

Panel Discussions: Cross-regional Commitment to Health Innovation for Equity and Access

Speakers from A*Star, the Experimental Drug Development Centre (EDDC), JLABS Singapore, CBC Group, and PATH South Asia shared insights on fostering innovation in the APAC life sciences sector. The panel explored strategies to advance R&D, overcome regulatory fragmentation, and promote sustainable investments, emphasizing the importance of building a collaborative ecosystem. Dr Alessandro Falcone, Regional Head of JLABS Singapore, outlined the three key pillars necessary for life science innovation: science, expertise, and funding. “In the current volatile landscape, companies that pivot and adapt quickly are the ones that thrive. This includes reassessing product focus, geographic strategy, and even leadership structure,” he emphasized.

In the “Innovator Showcase” session, leaders from BeiGene, Pilatus Biosciences, Hugo Biotech presented examples of cutting-edge Asian life sciences innovation for the region as well as the global market.? For instance, the digital transformation of pathology, highlighting automating complex procedures and centralizing sequencing analysis, has led to a substantial reduction of costs and accuracy of microbiology testing.

The afternoon session began with the topic of “Creating a Vibrant Life Sciences Market in APAC”, in partnership with DBS Bank, GenScript and Sino-Innovax. The showcase session featured leading organisations of the life science innovation value chain, including GenScript, ATLATL Scientific, SG Diagnostics, and George Clinical. Dr Janice Jin, President of GenScript Asia Pacific, highlighted the company’s four-pronged approach: “We’ve made meaningful impacts in supporting local research, engaging with the community, nurturing local talent, and fulfilling corporate social responsibilities.”

The panels, “Partnering for Success: A Dialogue” and “Innovative Financing for Improved Access,” explored strategies to advance APAC’s life sciences market through cross sectoral and cross regional collaboration and sustainable innovative financing. Moderated by Giles Newmarch, Senior Investment Officer, lFC-International Finance Corporation (World Bank) and Dale Huntington, Senior Director, Health Care Systems Policy, Johnson and Johnson, the panels featured leaders from DBS Bank, Sino-Innovax Biotec, Diagnostics Development Hub, SCG Cell Therapy, Microsoft, Access Partnership, Pfizer, MSD Pharma, MSD for Mothers, aEQ, Heals Healthcare and MiyaHealth. Discussions focused on leveraging partnerships, technology to develop and bring more innovations to the market, as well as through tailored financing models to address improve access, bridge funding gaps, and drive innovation. Dr Eugene Hong, Head, Healthcare & Pharmaceutical at the Institutional Banking Group, DBS Bank, underscored the importance of a compelling narrative to attract investment. “Investors are drawn to projects that address pressing societal challenges. By framing key issues as urgent and solvable, we can mobilize capital more effectively”.

The next session, “the Asia Life Sciences Investor Forum”, was held in partnership with Haitong International. The panels, “Global Investment Supporting Asia Life Sciences Industry” and “Asian Investment Facilitating Regional Life Sciences Industry Cooperation,” highlighted the pivotal role of investment in advancing Asia’s life sciences ecosystem. Moderated by Stephen Ng, Managing Director and CEO of CICC Singapore, and Barney YAO Executive Director of Equity Research, Chief AI Strategist at Haitong International, the discussions brought together leaders from B Capital Group, the International Finance Corporation (IFC), EDBI, ABC Impact, Boehringer Ingelheim Venture Fund, VMS Group and LYFE Capital. The panel emphasized the pressing need to address financing gaps, noting that governments across the APAC region are grappling with the dual challenge of aging populations and shifting disease burdens, all while navigating economic pressures. They explored various strategies to expand the fiscal space for health, including leveraging non-traditional funding mechanisms, public-private partnerships, and outcome-based financing models.

The day one program also featured a “Singapore Night” networking dinner, in partnership with SGX Group and Han Kun Law Offices, highlighting by keynote speeches from Dr Wei Yang Cheong, Vice Provost at Singapore Management University and Senior Adviser (Health Economics) at the Ministry of Health, Singapore, Jin Hoe Koh, Executive Director at SGX Group and Aaron GU Partner of Han Kun Law Offices.

Creating a Climate-Resilient Health Future for Asia

?

The second day of the summit, in partnership with CIIP, opened with remarks by Deepali Khanna, Vice President for Asia at the Rockefeller Foundation, highlighting the critical need for innovative solutions and partnerships to address the region’s pressing healthcare and climate challenges.

This was followed by a panel on “The Impact of Climate Change on Health”, calling for industry action, moderated by Hong Ma, Executive Vice President, Advocacy and Engagement at Edelman APAC Health, featuring leaders from Global Asia Insurance Partnership (GAIP), the Health and Global Policy Institute (HGPI), the Asia Infrastructure Investment Bank (AIIB), and the World Economic Forum. Panellists explored the wide-ranging health impacts of climate change and emphasized the need for industry-wide action to build robust, adaptable healthcare systems in the region.

Building on this theme, followed a panel on “Decarbonizing the Healthcare Sector in Asia”, moderated by Jean-Gaetan GUILLEMAUD, Vice President Corporate Affairs, Zuellig Pharma, and convening leaders from SingHealth, DBS Bank, Philips, Roche and Apollo Hospitals. Discussions focused on reducing the healthcare sector’s carbon footprint and implementing sustainable practices through innovative supply chain strategies and cross-sector collaboration. ?“As we pursue our decarbonisation journey, our efforts fall into two main categories: infrastructure and culture. While the infrastructure aspect is straightforward, the cultural shift requires more attention. It’s not that our colleagues don’t care—they do. But we need to make it easy for them to do the right thing: to recycle, to reuse, and to actively participate in the sustainability journey amidst their demanding clinical responsibilities,” shared Professor Wan Cheng Chow, Group Director of Academic Medicine at SingHealth HQ and Vice Dean of Office of Academic Medicine at Duke-NUS School of Medicine.

Panel Discussions: Decarbonizing the Healthcare Sector in Asia

Showcase presentations followed, highlighting innovative solutions at the intersection of climate change and health. Representatives from the Centre for Impact Investing and Practices (CIIP), DBS Bank, the Embassy of the Kingdom of the Netherlands, and Landcent Group shared successful projects that demonstrated the power of public-private partnerships in creating scalable, sustainable solutions.

The summit concluded with a forward-looking panel on climate-resilient health systems, moderated by Renzo R. Guinto, Associate Professor of Global and Planetary Health at the SingHealth Duke-NUS Global Health Institute. Panellists from Bayer Foundation, Yale School of Public Health, Singapore University of Social Sciences (SUSS), Microsoft, and Digital Health China Technologies discussed strategies for enhancing health infrastructure, securing investment, and driving regional cooperation to address growing climate challenges. This comprehensive exploration of climate and health underscored the importance of collaboration, innovation, and policy action in building a sustainable and resilient future for healthcare across APAC. The panel discussed practical tools and strategies to drive resilience, such as automating processes, addressing social norms, and implementing standardized checklists. Specific examples included national disease surveillance systems, data-sharing platforms, and the integration of carbon tracking into digital health solutions.

Summit moderators (from left to right): Associate Professor Jonas KARLSTR?M, Core Lead of Innovation in Global Health at SingHealth Duke-NUS Global Health Institute, and Dr Chang LIU, Founder & CEO of ASK Health Asia and Adjunct Associate Professor at the Chinese University of Hong Kong

In closing remarks, Dr Chang Liu, the founder and CEO of Ask Health Asia expressed gratitude to all participants – speakers and attendees and noted the importance of continued collaboration across the Asia-Pacific region. Dr Chang Liu reflected, “This summit underscores the vital role APAC countries play in global healthcare innovation. By harnessing our shared strengths and fostering cooperation, we are building a future where healthcare is accessible, equitable, and resilient to climate impacts.”

For more information and to stay updated on APACLIFE2024, please visit the official website.

?

About SingHealth Duke-NUS Global Health Institute

The SingHealth Duke-NUS Global Health Institute (SDGHI) aims to advance health and wellbeing in Asia and beyond. Working in collaboration with partners, the Institute seeks to strengthen health systems, improve health outcomes and increase health security. Launched in 2018, SDGHI harnesses the capacity of SingHealth, the largest group of health care institutions in Singapore, and the Duke-NUS Medical School, to advance interdisciplinary global health research and capacity development across the region.

www.duke-nus.edu.sg/sdghi

About ASK Health Asia

ASK Health Asia is an Asia based think tank, consultancy, and venture builder in healthcare. Headquartered in Singapore, ASK Health Asia has extensive experience and operations in Southeast Asia, Mainland China, and Macau, with close partnership in India, Japan, Korea, Australia, and Middle East. ASK Health is a premier catalyst for health systems transformation in Asia. Through in-depth research, consultancy, platform development, solution co-creation and resource connection, we work closely with development partner, governments, and industry leaders to jointly capture growth opportunities from new health policies and provide innovative solutions to the economies across Asia.

www.askhealthasia.com?/?m.nbpvnlb.cn

The post 2024 APAC Health and Life Sciences Summit: Global Leaders Gather to Shape a Sustainable and Resilient Future of Healthcare appeared first on 艾社康（上海）健康咨詢有限公司.

1月23日，在洛克菲勒基金會(huì)（The Rockefeller Foundation）的支持下，艾社康在曼谷PMAC 2024大會(huì)期間成功舉辦“科技創(chuàng)新助力建設(shè)有氣候韌性的城市和衛(wèi)生系統(tǒng)”研討會(huì)。

活動(dòng)匯集了來(lái)自學(xué)術(shù)、公共衛(wèi)生和慈善事業(yè)最前沿的跨部門領(lǐng)袖，共同探討中國(guó)在氣候-健康領(lǐng)域的創(chuàng)新、對(duì)亞洲地區(qū)的影響以及未來(lái)可能的合作方向。

在本次研討會(huì)中，艾社康正式發(fā)布了《Leveraging Data-Driven Solutions in Confronting Climate-Sensitive Diseases: China Case Study》報(bào)告。

（掃描下方二維碼 即可下載報(bào)告全文）

The post 艾社康于PMAC 2024大會(huì)期間舉辦“科技創(chuàng)新助力建設(shè)有氣候韌性的城市和衛(wèi)生系統(tǒng)”研討會(huì) appeared first on 艾社康（上海）健康咨詢有限公司.

由諾華公司組織和資助的 “患者創(chuàng)新和解決方案國(guó)際聯(lián)盟”（APPIS）平臺(tái)成立于 2021 年，旨在將患者社區(qū)和醫(yī)療保健生態(tài)系統(tǒng)中的主要利益相關(guān)者聚集在一起，優(yōu)先采取行動(dòng)，解決該地區(qū)患者在就醫(yī)過(guò)程中遇到的障礙。

自 APPIS 成立以來(lái)，已有來(lái)自 60 多個(gè)國(guó)家的 2,000 多人（包括 400 個(gè)患者組織、政策制定者、支付方、醫(yī)生、學(xué)者和數(shù)字創(chuàng)新者）在 APPIS 平臺(tái)上匯聚一堂，就患者創(chuàng)新和解決方案交流想法并開(kāi)展合作。

艾社康榮幸受諾華集團(tuán)邀請(qǐng)，成為“患者創(chuàng)新和解決方案國(guó)際聯(lián)盟”的理事會(huì)成員。歡迎關(guān)注今年的APPIS全球峰會(huì)以及在亞太區(qū)域的系列項(xiàng)目。一起齊聚，只為患者！

The post 艾社康受邀成為“患者創(chuàng)新和解決方案國(guó)際聯(lián)盟”（APPIS）的理事會(huì)成員 appeared first on 艾社康（上海）健康咨詢有限公司.

2024年1月16日，艾社康在香港賽馬會(huì)、公益慈善研究院和世界經(jīng)濟(jì)論壇支持下，于北京舉辦“A Dialogue on Digital Innovation and AI Integration in Healthcare”圓桌研討會(huì)。

本次活動(dòng)匯集了30余位來(lái)自政府間組織、慈善基金會(huì)、學(xué)術(shù)界和私營(yíng)部門的創(chuàng)新領(lǐng)導(dǎo)者們，共同討論AI等新興技術(shù)于衛(wèi)生體系轉(zhuǎn)型的價(jià)值與挑戰(zhàn)，并邀各方領(lǐng)袖共同探索未來(lái)合作。

The post 艾社康舉辦“A Dialogue on Digital Innovation and AI Integration in Healthcare”圓桌研討會(huì) appeared first on 艾社康（上海）健康咨詢有限公司.

12月16日，世界經(jīng)濟(jì)論壇與北京康盟慈善基金會(huì)共同發(fā)起舉辦了“關(guān)注精神健康，回歸美好生活”閉門研討會(huì)，會(huì)議由勃林格殷格翰與艾社康共同支持。

會(huì)議從精神衛(wèi)生服務(wù)體系的加強(qiáng)，污名化的消除，疾病預(yù)防與臨床診斷，社會(huì)力量支持等角度開(kāi)展討論，助力支持精神疾病患者真正的回歸家庭回歸生活。

本次會(huì)議邀請(qǐng)了衛(wèi)健委規(guī)劃司毛群安司長(zhǎng)、國(guó)家心理健康和精神衛(wèi)生防治中心姚宏文主任、以及來(lái)自北大六院、上海精神衛(wèi)生中心、天津安定醫(yī)院、河北醫(yī)科大學(xué)精神衛(wèi)生中心等醫(yī)療機(jī)構(gòu)的院領(lǐng)導(dǎo)等專家共同參與討論。

The post 世界經(jīng)濟(jì)論壇與北京康盟慈善基金會(huì)“關(guān)注精神健康，回歸美好生活”閉門研討會(huì)成功召開(kāi) appeared first on 艾社康（上海）健康咨詢有限公司.

2023年12月16-17日，粵港澳大灣區(qū)醫(yī)療衛(wèi)生事業(yè)協(xié)同發(fā)展高峰論壇在廣州成功召開(kāi)。此次論壇由中國(guó)醫(yī)藥保健品進(jìn)出口商會(huì)、中國(guó)醫(yī)藥教育協(xié)會(huì)、中國(guó)健康促進(jìn)基金會(huì)與北京康盟慈善基金會(huì)聯(lián)合發(fā)起，黃埔社會(huì)科學(xué)高等研究院、艾社康（上海）健康咨詢有限公司承辦。

廣州開(kāi)發(fā)區(qū)管委會(huì)為本次活動(dòng)提供合作支持，輝瑞中國(guó)、第一三共、阿斯利康、再鼎醫(yī)藥、云頂新耀、艾伯維、藥明巨諾等多家行業(yè)領(lǐng)軍企業(yè)齊聚一堂，共同圍繞政策趨勢(shì)、熱點(diǎn)話題進(jìn)行深入探討與交流。論壇獲得央視頻作為媒體支持平臺(tái)，南方日?qǐng)?bào)、廣州日?qǐng)?bào)、澳門日?qǐng)?bào)、新浪財(cái)經(jīng)、八點(diǎn)健聞、E藥經(jīng)理人、醫(yī)學(xué)界提供合作支持，攜手?jǐn)?shù)家媒體平臺(tái)進(jìn)行宣傳報(bào)道。

艾社康由衷感謝合作方和與會(huì)專家的大力支持和精彩分享。期待各方通力合作，持續(xù)推進(jìn)“三地””三醫(yī)”互聯(lián)融合，共同助力健康灣區(qū)建設(shè)。

The post 粵港澳大灣區(qū)醫(yī)療衛(wèi)生事業(yè)協(xié)同發(fā)展高峰論壇圓滿落幕 appeared first on 艾社康（上海）健康咨詢有限公司.

2023年12月6日，為期兩天的第二屆默沙東創(chuàng)新準(zhǔn)入論壇在杭州召開(kāi)，艾社康榮幸受邀連續(xù)兩天參與論壇活動(dòng)，和默沙東LT團(tuán)隊(duì)以及行業(yè)大咖共同交流。期待MSD中國(guó)，特別是創(chuàng)新準(zhǔn)入團(tuán)隊(duì)牽手伙伴、融合發(fā)展、持續(xù)引領(lǐng)。

The post 艾社康受邀參加第二屆默沙東創(chuàng)新準(zhǔn)入論壇 appeared first on 艾社康（上海）健康咨詢有限公司.

2023年11月30日，為期兩天的“第七屆全球老齡化論壇”在首爾召開(kāi)，論壇旨在探討老齡化、健康等全球問(wèn)題。

艾社康很榮幸受邀參加，在圓桌論壇環(huán)節(jié)，與印尼發(fā)展改革部副部長(zhǎng)、韓國(guó)社會(huì)保障中心主任、馬拉西亞養(yǎng)老金主席共同探討，交流各國(guó)建設(shè)長(zhǎng)期照護(hù)保險(xiǎn)的經(jīng)驗(yàn)，期待多邊交流與系統(tǒng)合作。

The post 艾社康受邀參加UNFPA聯(lián)合國(guó)人口發(fā)展基金舉辦的首爾“第七屆全球老齡化論壇” appeared first on 艾社康（上海）健康咨詢有限公司.

11月27日，中國(guó)僑聯(lián)與澳門歸僑總會(huì)主辦，澳門僑界十五個(gè)屬會(huì)、團(tuán)體會(huì)員及友會(huì)共同協(xié)辦的 “ 2023華僑華人助力‘一帶一路’高質(zhì)量發(fā)展大會(huì)”在澳門塔會(huì)展中心舉行。

此次大會(huì)由中華全國(guó)歸國(guó)華僑聯(lián)合會(huì)和澳門歸僑總會(huì)共同舉辦，旨在讓海外僑領(lǐng)深入了解澳門“一國(guó)兩制”成功實(shí)踐和城市新風(fēng)貌，發(fā)揮融通中外的獨(dú)特優(yōu)勢(shì)，為書(shū)寫澳門高質(zhì)量發(fā)展新篇章貢獻(xiàn)僑界智慧和力量，同時(shí)進(jìn)一步助力澳門發(fā)揮海上絲路節(jié)點(diǎn)作用，促進(jìn)與“一帶一路”共建國(guó)家和地區(qū)在多層面、各領(lǐng)域的交流與合作。

艾社康亞洲很榮幸受邀參加，并加入“大灣區(qū)金融發(fā)展協(xié)會(huì)”，以期待推動(dòng)粵港澳大灣區(qū)醫(yī)療健康保險(xiǎn)融合發(fā)展。

The post 艾社康亞洲受邀參加紀(jì)念“一帶一路”倡議十周年“中國(guó)澳門·世界舞臺(tái)——華僑華人助力‘一帶一路’高質(zhì)量發(fā)展大會(huì)” appeared first on 艾社康（上海）健康咨詢有限公司.